Plasmodium falciparum malaria
MONDO:0005920Malaria resulting from infection by Plasmodium falciparum.
Also known as: Plasmodium falciparum malaria, unspecified, falciparum malaria, falciparum malaria [malignant tertian], malignant tertian fever (finding)
82 clinical trials for this condition and its sub-types, 79 tagged with Plasmodium falciparum malaria itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Can a new vaccine stop malaria in its tracks?
Vaccine Stopped earlyThis early-stage trial is testing a new malaria vaccine candidate, called Pfs48/45, in healthy adults aged 18 to 45 in the UK. The vaccine is designed to block the malaria parasite from spreading, and it's given with an adjuvant called Matrix-M to boost the immune response. The s…
Early phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
New malaria pill for tiny infants studied, but trial stopped early
Disease control Stopped earlyThis study tested a new, easy-to-dissolve malaria tablet in infants and newborns weighing less than 5 kg who had uncomplicated malaria. The goal was to see how the medicine worked in the body, how safe it was, and how well it treated the infection. The trial was stopped early aft…
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC